Chronic Bacterial Prostatitis due to Staphylococcus haemolyticus; Case Report

Prostatitis causes up to 25% of male genitourinary complaint. However, due to technical restrictions in sampling, only in 10% of cases pathogens were identified. In this paper, a patient with chronic prostatitis due to Staphylococcus hemolyticus is described. A 48-year-old man was referred with long...

Full description

Bibliographic Details
Main Authors: Sholeh Ebrahimpour, Sirous Jafari
Format: Article
Language:English
Published: Research Center for Rational Use of Drugs (RCRUD) 2018-05-01
Series:Journal of Pharmaceutical Care
Subjects:
Online Access:https://jpc.tums.ac.ir/index.php/jpc/article/view/161
_version_ 1818056154215874560
author Sholeh Ebrahimpour
Sirous Jafari
author_facet Sholeh Ebrahimpour
Sirous Jafari
author_sort Sholeh Ebrahimpour
collection DOAJ
description Prostatitis causes up to 25% of male genitourinary complaint. However, due to technical restrictions in sampling, only in 10% of cases pathogens were identified. In this paper, a patient with chronic prostatitis due to Staphylococcus hemolyticus is described. A 48-year-old man was referred with longstanding (approximately for 18 months) complaint of increased genitourinary symptoms and pain in perineum. In evaluation, moderate growth of methicillin-resistant Staphylococcus hemolyticus (MRSH) in post-prostatic massage voided urine and expressed prostatic secretion (EPS) was positive. Culture of urethral urine (urine or voided bladder 1; VB1), midstream urine (VB2) and post-ejaculation urine specimens were negative. Leukocyte count values in EPS and post-prostatic massage voided urine were 14 and 8 per oil immersion field respectively. PCR of urine samples was positive for Ureaplasma urealyticum and confirmed by repeated analysis. Based on the antimicrobial susceptibility results patient was treated with teicoplanin 400 mg intramuscularly every 12 hours for three doses followed by the daily maintenance dose of 400 mg.  In addition, doxycycline 100 mg twice daily was added to cover Ureaplasma urealyticum. Treatment course completed in 6 weeks. Alleviation of patient’s symptoms begun within the first week of treatment and this trend continued until the end of the treatment.
first_indexed 2024-12-10T12:24:20Z
format Article
id doaj.art-90791ac2cce346aba6bb53107287f23a
institution Directory Open Access Journal
issn 2322-4630
2322-4509
language English
last_indexed 2024-12-10T12:24:20Z
publishDate 2018-05-01
publisher Research Center for Rational Use of Drugs (RCRUD)
record_format Article
series Journal of Pharmaceutical Care
spelling doaj.art-90791ac2cce346aba6bb53107287f23a2022-12-22T01:48:59ZengResearch Center for Rational Use of Drugs (RCRUD)Journal of Pharmaceutical Care2322-46302322-45092018-05-0151-2115Chronic Bacterial Prostatitis due to Staphylococcus haemolyticus; Case ReportSholeh Ebrahimpour0Sirous Jafari1Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, IranDepartment of Infectious Diseases, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.Prostatitis causes up to 25% of male genitourinary complaint. However, due to technical restrictions in sampling, only in 10% of cases pathogens were identified. In this paper, a patient with chronic prostatitis due to Staphylococcus hemolyticus is described. A 48-year-old man was referred with longstanding (approximately for 18 months) complaint of increased genitourinary symptoms and pain in perineum. In evaluation, moderate growth of methicillin-resistant Staphylococcus hemolyticus (MRSH) in post-prostatic massage voided urine and expressed prostatic secretion (EPS) was positive. Culture of urethral urine (urine or voided bladder 1; VB1), midstream urine (VB2) and post-ejaculation urine specimens were negative. Leukocyte count values in EPS and post-prostatic massage voided urine were 14 and 8 per oil immersion field respectively. PCR of urine samples was positive for Ureaplasma urealyticum and confirmed by repeated analysis. Based on the antimicrobial susceptibility results patient was treated with teicoplanin 400 mg intramuscularly every 12 hours for three doses followed by the daily maintenance dose of 400 mg.  In addition, doxycycline 100 mg twice daily was added to cover Ureaplasma urealyticum. Treatment course completed in 6 weeks. Alleviation of patient’s symptoms begun within the first week of treatment and this trend continued until the end of the treatment.https://jpc.tums.ac.ir/index.php/jpc/article/view/161ProstatitisStaphylococcus hemolyticusTeicoplanin
spellingShingle Sholeh Ebrahimpour
Sirous Jafari
Chronic Bacterial Prostatitis due to Staphylococcus haemolyticus; Case Report
Journal of Pharmaceutical Care
Prostatitis
Staphylococcus hemolyticus
Teicoplanin
title Chronic Bacterial Prostatitis due to Staphylococcus haemolyticus; Case Report
title_full Chronic Bacterial Prostatitis due to Staphylococcus haemolyticus; Case Report
title_fullStr Chronic Bacterial Prostatitis due to Staphylococcus haemolyticus; Case Report
title_full_unstemmed Chronic Bacterial Prostatitis due to Staphylococcus haemolyticus; Case Report
title_short Chronic Bacterial Prostatitis due to Staphylococcus haemolyticus; Case Report
title_sort chronic bacterial prostatitis due to staphylococcus haemolyticus case report
topic Prostatitis
Staphylococcus hemolyticus
Teicoplanin
url https://jpc.tums.ac.ir/index.php/jpc/article/view/161
work_keys_str_mv AT sholehebrahimpour chronicbacterialprostatitisduetostaphylococcushaemolyticuscasereport
AT sirousjafari chronicbacterialprostatitisduetostaphylococcushaemolyticuscasereport